M. Sayiner, A. Koenig, L. Henry, and Z. M. Younossi, Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in the United States and the rest of the world, Clin. Liver Dis, vol.20, pp.205-214, 2016.

M. Gaggini, Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease, Nutrients, vol.5, pp.1544-1560, 2013.

C. Bertot, L. Adams, and L. A. , The natural course of non-alcoholic fatty liver disease, Int. J. Mol. Sci, vol.17, p.774, 2016.

A. Mantovani, C. D. Byrne, E. Bonora, and G. Targher, Nonalcoholic fatty liver disease and risk of incident Type 2 diabetes: a meta-analysis, Diabetes Care, vol.41, pp.372-382, 2018.

G. Targher, C. D. Byrne, A. Lonardo, G. Zoppini, and C. Barbui, Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis, J. Hepatol, vol.65, pp.589-600, 2016.

S. Lim, T. J. Oh, and K. K. Koh, Mechanistic link between nonalcoholic fatty liver disease and cardiometabolic disorders, Int. J. Cardiol, vol.201, pp.408-414, 2015.

G. Targher and C. D. Byrne, Clinical review: nonalcoholic fatty liver disease: a novel cardiometabolic risk factor for type 2 diabetes and its complications, J. Clin. Endocrinol. Metab, vol.98, pp.483-495, 2013.

G. Targher, C. P. Day, and E. Bonora, Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease, N. Engl. J. Med, vol.363, pp.1341-1350, 2010.

B. Brouwers, Metabolic disturbances of non-alcoholic fatty liver resemble the alterations typical for type 2 diabetes, Clin. Sci, vol.131, pp.1905-1917, 1979.

N. Matikainen, Hepatic lipogenesis and a marker of hepatic lipid oxidation, predict postprandial responses of triglyceride-rich lipoproteins, Obesity (Silver Spring, Md.), vol.22, pp.1854-1859, 2014.

J. E. Lambert, M. A. Ramos-roman, J. D. Browning, and E. Parks, Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease, Gastroenterology, vol.146, pp.726-735, 2014.

N. L. Gluchowski, Hepatocyte deletion of triglyceride-synthesis enzyme acyl CoA: diacylglycerol acyltransferase 2 reduces steatosis without increasing inflammation or fibrosis in mice, Hepatology, vol.70, pp.1972-1985, 2019.

F. Benhamed, The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans, J. Clin. Investig, vol.122, pp.2176-2194, 2012.
URL : https://hal.archives-ouvertes.fr/hal-02649316

P. Puri, A lipidomic analysis of nonalcoholic fatty liver disease, Hepatology (Baltim., Md.), vol.46, pp.1081-1090, 2007.

J. Araya, Increase in long-chain polyunsaturated fatty acid n -6/n -3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease, Clin. Sci, vol.106, pp.635-643, 1979.

N. A. Johnson, Noninvasive assessment of hepatic lipid composition: advancing understanding and management of fatty liver disorders, Hepatology (Baltim., Md.), vol.47, pp.1513-1523, 2008.

G. Hamilton, In vivo characterization of the liver fat (1)H MR spectrum, NMR Biomed, vol.24, pp.784-790, 2011.

J. Lundbom, Long-TE 1H MRS suggests that liver fat is more saturated than subcutaneous and visceral fat, NMR Biomed, vol.24, pp.238-245, 2011.

M. Gajdosik, Ultrashort-TE stimulated echo acquisition mode (STEAM) improves the quantification of lipids and fatty acid chain unsaturation in the human liver at 7 T, NMR Biomed, vol.28, pp.1283-1293, 2015.

K. L. Donnelly, Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease, J. Clin. Investig, vol.115, pp.1343-1351, 2005.

R. H. Bandsma, Increased de novo lipogenesis and delayed conversion of large VLDL into intermediate density lipoprotein particles contribute to hyperlipidemia in glycogen storage disease type 1a, Pediatr. Res, vol.63, pp.702-707, 2008.

L. C. Hudgins, T. S. Parker, D. M. Levine, and M. K. Hellerstein, A dual sugar challenge test for lipogenic sensitivity to dietary fructose, J. Clin. Endocrinol. Metab, vol.96, pp.861-868, 2011.

A. Peter, Relationships between hepatic stearoyl-CoA desaturase-1 activity and mRNA expression with liver fat content in humans, Am. J. Physiol. Endocrinol. Metab, vol.300, pp.321-326, 2011.

M. T. Timlin, B. R. Barrows, and E. Parks, Increased dietary substrate delivery alters hepatic fatty acid recycling in healthy men, Diabetes, vol.54, pp.2694-2701, 2005.

L. Hodson, Hepatic fatty acid synthesis and partitioning: the effect of metabolic and nutritional state, Proc. Nutr. Soc, vol.78, pp.126-134, 2019.

C. W. Kim, Acetyl CoA carboxylase inhibition reduces hepatic steatosis but elevates plasma triglycerides in mice and humans: a bedside to bench investigation, Cell Metab, vol.26, p.396, 2017.

R. Loomba, GS-0976 reduces hepatic steatosis and fibrosis markers in patients with nonalcoholic fatty liver disease, Gastroenterology, vol.155, p.1466, 2018.

E. J. Lawitz, Acetyl-CoA carboxylase inhibitor GS-0976 for 12 weeks reduces hepatic de novo lipogenesis and steatosis in patients with nonalcoholic steatohepatitis, Clin. Gastroenterol. Hepatol, vol.16, 1983.

J. Frahm, Localized high-resolution proton NMR spectroscopy using stimulated echoes: initial applications to human brain in vivo, Magn. Reson. Med, vol.9, pp.79-93, 1989.

I. Tkac, Z. Starcuk, I. Y. Choi, and R. Gruetter, In vivo 1H NMR spectroscopy of rat brain at 1 ms echo time, Magn. Reson. Med, vol.41, pp.649-656, 1999.

Z. Dong, W. Dreher, and D. Leibfritz, Experimental method to eliminate frequency modulation sidebands in localized in vivo 1H MR spectra acquired without water suppression, Magn. Reson. Med, vol.51, pp.602-606, 2004.

F. Diraison, C. Pachiaudi, and M. Beylot, In vivo measurement of plasma cholesterol and fatty acid synthesis with deuterated water: determination of the average number of deuterium atoms incorporated, Metab.: Clin. Exp, vol.45, pp.817-821, 1996.

P. Dempster and S. Aitkens, A new air displacement method for the determination of human body composition, Med. Sci. Sports Exerc, vol.27, pp.1692-1697, 1995.

W. E. Siri, Body composition from fluid spaces and density: analysis of methods, Nutrition, vol.9, p.492, 1961.

L. Lofgren, The BUME method: a novel automated chloroform-free 96-well total lipid extraction method for blood plasma, J. Lipid Res, vol.53, pp.1690-1700, 2012.

L. Lofgren, G. B. Forsberg, and M. Stahlman, The BUME method: a new rapid and simple chloroform-free method for total lipid extraction of animal tissue, Sci. Rep, vol.6, p.27688, 2016.

R. C. Murphy, Detection of the abundance of diacylglycerol and triacylglycerol molecular species in cells using neutral loss mass spectrometry, Anal. Biochem, vol.366, pp.59-70, 2007.

R. Steele, Influences of glucose loading and of injected insulin on hepatic glucose output, Ann. N. Y. Acad. Sci, vol.82, pp.420-430, 1959.